Dirty air and blood clots: the link may be real but it is small and shaky

Air pollution is one of the most heavily studied environmental exposures in medicine, and its association with cardiovascular illness and death is well established. What has stayed uncertain is whether breathing particulate matter also raises the risk of venous thromboembolism, the clots that form in veins and can travel to the lungs. Because almost everyone is exposed to some level of particulate pollution, even a small increase in risk would matter at population scale. This updated review set out to pool everything published so far on particulate matter and venous clotting outcomes.

The researchers searched PubMed, Embase, Web of Science and the Cochrane Library for studies that followed people and recorded both their exposure to PM2.5 or PM10 pollution and any venous thrombotic events. Nineteen studies met the inclusion criteria, together representing more than 4.5 million participants. Studies were sorted by pollutant, by how long the exposure lasted and by how effects were reported, and exposure estimates were harmonised to a common unit of 10 μg/m³. Results were then pooled using statistical models designed to cope with disagreement between studies.

The headline result was null: overall long-term analyses showed no significant association for PM2.5 (hazard ratio 1.42) or PM10 (hazard ratio 1.18), and the individual studies disagreed with each other enormously. The picture changed in sensitivity analyses restricted to studies that natively reported effects per 10 μg/m³: there, PM2.5 showed a modest association with venous clots (hazard ratio 1.070) and PM10 a borderline one (hazard ratio 1.023), with the remaining studies in close agreement. Short-term exposure to either pollutant showed no significant link with venous thrombotic risk.

Pollution's link to arterial disease, meaning heart attacks and strokes, is firmly established, but the venous side has long been murkier, and this update keeps it that way. The finding that the association appears or vanishes depending on how exposure was measured is itself informative: it suggests any real effect is modest and easily hidden by inconsistent methods. The authors call for standardised exposure metrics and consistent definitions of venous thromboembolism before the question can be settled. Whether the modest PM2.5 signal is genuine remains the open question.

For an individual reader, this is not a finding to worry about: the overall analysis found no clear association, and the signal that did appear was small. It is, at most, one more possible entry on the long list of reasons cleaner air is worth caring about. Nothing here suggests day-to-day exposure decisions would measurably change anyone's clot risk. The honest summary is that scientists still do not know whether this link exists, and if it does, it looks modest.